EPENDYMOMA
Clinical trials for EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA trials appear
Sign up with your email to follow new studies for EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab test picks drugs for incurable brain tumors
Disease control Not yet recruitingThis study tests a new approach for people with brain tumors that have not responded to standard treatments. A lab test called pharmacoscopy analyzes a patient's tumor cells to find which drugs might work best for them. The goal is to see if this personalized method is feasible a…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New vaccine combo aims to fight deadly childhood brain cancers
Disease control Not yet recruitingThis early-stage trial tests a combination of a vaccine targeting a common virus (CMV) and an immunotherapy drug (nivolumab) in children and young adults with aggressive brain tumors like diffuse midline glioma and medulloblastoma. The goal is to see if this approach is safe and …
Matched conditions: EPENDYMOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New proton therapy aims to shield Kids' bones during brain tumor radiation
Disease control Not yet recruitingThis study tests a special proton therapy technique that avoids radiating the growing parts of the spine in children with brain tumors. The goal is to preserve bone marrow and reduce side effects like growth problems. About 38 children and teens will be followed for up to 5 years…
Matched conditions: EPENDYMOMA
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Immune cells engineered to attack brain tumors in kids: new trial launches
Disease control Not yet recruitingThis early-phase study tests a personalized cell therapy called B7-H3 CAR T cells in 70 children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a prote…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Virus injected into brain tumors shows promise for kids with no other options
Disease control Not yet recruitingThis study tests a treatment called DNX-2401, a virus that is injected directly into brain tumors to kill cancer cells. It is for children and young adults (up to age 39) whose high-grade brain tumors have come back or not responded to standard treatments. The goal is to see if t…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC